Comparison Overview
Jubilant Therapeutics Inc

Jubilant Therapeutics Inc
790, Township Line Road, Suite 175, Yardley, 19067, US
Last Update: 24/12/2025
Jubilant Therapeutics is a patient-focused biopharmaceutical company advancing potent and selective small molecule modulators to address specific unmet medical needs in oncology and autoimmune diseases. The company’s leadership and scientific team are science-driven exe...

Regeneron
777 Old Saw Mill River Road, Tarrytown, 10591, US
Last Update: 20/05/2026
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new w...
Compliance Ranges Comparison

Jubilant Therapeutics Inc







Regeneron






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Industry Avg (This Year)
No incidents recorded for Jubilant Therapeutics Inc in 2026.
Incidents vs Biotechnology Industry Avg (This Year)
No incidents recorded for Regeneron in 2026.
Incident History - Jubilant Therapeutics Inc (X = Date, Y = Severity)
Jubilant Therapeutics Inc cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Regeneron (X = Date, Y = Severity)
Regeneron cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Jubilant Therapeutics Inc

Regeneron
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.